A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis March 29, 2023 from Neurology : nature.com subject feeds https://ift.tt/MhAs8f9 Share Get link Facebook X Pinterest Email Other Apps Labels Neurology : nature.com subject feeds NeuroNature Share Get link Facebook X Pinterest Email Other Apps Comments
Comments
Post a Comment